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Abstract
Background This review provides a reappraisal of the
potential effects of dairy foods, including dairy fats, on
cardiovascular disease (CVD)/coronary heart disease
(CHD) risk. Commodities and foods containing saturated
fats are of particular focus as current public dietary
recommendations are directed toward reducing the intake
of saturated fats as a means to improve the overall health of
the population. A conference of scientists from different
perspectives of dietary fat and health was convened in
order to consider the scientific basis for these
recommendations.
Aims This review and summary of the conference focus
on four key areas related to the biology of dairy foods and
fats and their potential impact on human health: (a) the
effect of dairy foods on CVD in prospective cohort studies;
(b) the impact of dairy fat on plasma lipid risk factors for
CVD; (c) the effects of dairy fat on non-lipid risk factors
for CVD; and (d) the role of dairy products as essential
contributors of micronutrients in reference food patterns
for the elderly.
Conclusions Despite the contribution of dairy products to
the saturated fatty acid composition of the diet, and given
the diversity of dairy foods of widely differing composi-
tion, there is no clear evidence that dairy food consumption
is consistently associated with a higher risk of CVD. Thus,
recommendations to reduce dairy food consumption irre-
spective of the nature of the dairy product should be made
with caution.
Keywords Milk fat  Cardiovascular disease risk 
Saturated fatty acid
Introduction
Public dietary recommendations for suggested intakes of
macronutrients have targeted lowering total fat—specifi-
cally cholesterol, saturated fat and trans fat—intake as a
means to improve the overall health of the population.
These recommendations have been based on the
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assumption that saturated fat intake is associated with risk
of the accelerated development of artery disease and pre-
mature mortality from heart attack and stroke. These broad
recommendations to lower intake of fat have been trans-
lated by the food industry into a long-term objective of
diminishing these components from agricultural commod-
ities and foods. Industrial food processing has been acting
on this objective over many years to diminish fats, par-
ticularly saturated and industrially produced trans fats, in
foods. Altering fat can have important consequences to
overall diet. Dramatic alterations in consumption of dairy
products, because of their nutrient density, carry much
more impact on public health than do just the intakes of
total fat, saturated fat and cholesterol. Hence, it is appro-
priate to ask whether the scientific evidence in support of
this basic conclusion is complete and further to ask if the
implications of these recommendations, if brought to
practice, are consistent with overall health of the popula-
tion. A conference of scientists from different perspectives
of dietary fat and health was convened to examine the
complexity of dairy fat in relation to cardiovascular disease
(CVD) risk in the background of currently available liter-
ature, to identify gaps in knowledge and to put dairy fat
into the context of overall health. On average, bovine milk
contains about 33 g total lipid (fat) per liter. Triacylgly-
cerols, which account for about 95% of the lipid fraction,
are composed of fatty acids of different length (4–24 C
atoms), degree of saturation and positional specificity on
the glycerol backbone. Other milk lipids are diacylglycerol
(about 2% of the lipid fraction), cholesterol (less than
0.5%), phospholipids (about 1%) and free fatty acids (less
than 0.5% of total milk lipids). Milk fat is present as
complex globules with structural properties distinct from
other biological sources of fats. Finally, there is a variety of
phospholipids derived from the mammary plasma mem-
brane around each milk fat globule. A diversity of dairy
foods of widely differing composition is processed from
this unique raw material. This conference was convened to
examine the scientific evidence for the effects of dairy
product consumption and milk lipids in human diets on
overall health and the risk of CVD, the main forms of
which are coronary heart disease (CHD) and stroke.
The effect of dairy foods on CHD: a review of
prospective cohort studies
Diets containing dairy fats are thought to contribute to
CVD/CHD primarily by increasing saturated fat intake and
as a result, many advisory bodies recommend avoiding
high-fat dairy foods as part of a healthy diet [4, 21, 29].
The rationale for the association between dairy fat con-
sumption and CVD is that saturated fats increase plasma
cholesterol [66], which in turn is associated with increased
CVD [41]. There are conflicting data concerning the simple
relationship between dairy consumption and blood lipids
due in part to the complex composition of fatty acids [64,
115]. Dairy foods improve other CVD risk factors. Dairy
products are also rich in calcium, and two separate meta-
analyses reported an inverse relationship between higher
calcium intake and reduced blood pressure [3, 22]. Data
from large cohort studies may represent a wider range of
characteristics and level of exposure in a community set-
ting rather than the controlled environment of a
randomized trial. Hence, the aim of this section is to review
the relationship between dairy food consumption and death
from CVD/ischemic heart disease using data from pro-
spective cohort studies.
A review was undertaken to investigate the effect of
dairy consumption on CVD using prospective cohort
studies. A systematic search of electronic databases
identified studies relating dairy food intake in adulthood
to episodes or death from CVD, ischemic heart disease
and myocardial infarction. Included studies were assessed
for quality based on study methodology, validity of die-
tary assessment, success of follow-up, standardized
assessment of CVD, ischemic heart disease, or myocardial
infarction endpoints and appropriateness of statistical
adjustment. Data from 12 cohorts involving [280,000
subjects were included. Most studies had follow-up of
[80%, adjusted statistically for three or more confound-
ers, and used standard criteria to determine endpoints.
About half the studies used a validated food frequency
questionnaire, administered the questionnaire more than
once, or had a follow-up [20 years. Fewer than half the
studies involved subject’s representative of the general
population. Overall findings showed 7 of the 12 cohorts
found no association between dairy intake and CVD.
Three cohorts reported positive relationships between
dairy foods and CVD. One cohort reported a positive
relationship between CVD and butter, but a negative
relationship with cheese. Mixed findings from another
cohort suggested no association between dairy and CVD,
but showed a positive relationship with dairy protein in
subsequent follow-up.
Nearly all studies reviewed used statistical analysis
methods including logistic regression using Cox-regres-
sion analysis or a proportional hazard models to adjust for
confounders [2, 20, 33, 39, 47, 62, 74, 92, 95, 106, 108].
The number and type of potential confounders used for
statistical adjustment varied among studies, with most
including age, smoking, social class and gender (when
both genders were included). One study used a simple
analysis of linear correlation, which does not adjust for
confounders [65]. This review revealed no consistent
findings to support the concept that dairy food
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consumption is associated with a higher risk of CHD.
While there is no doubt that dairy foods contribute to the
intake of saturated fats [47], and an excess of saturated fat
intake has previously been associated with higher inci-
dence of CHD, the evidence extracted from these 12
prospective cohort studies does not consistently demon-
strate a direct relationship between the intake of dairy
foods and the risk of CVD.
Are dairy foods protective?
The current recommendations by health authorities and
governments to eat low-fat dairy in preference to high-
fat dairy foods was supported by the data published in
1999 from the Nurses Health Study [47], as this was the
only study included to examine high- versus low-fat
dairy foods. In this large study, the ratio of high-fat to
low-fat dairy food consumption was positively associ-
ated with an increased risk of CHD [47], even though
separate analyses of high-fat or low-fat dairy food intake
was not significantly associated with CHD. The most
prominent relationship was between the intake of satu-
rated fatty acids—particularly palmitic (16:0) acid—and
risk of CHD. Dairy foods contributed to the intake of
15% of the total dietary saturated fatty acids and 10% to
16:0 and 18:0 (stearic) acid. Beef consumption accoun-
ted for 23% of the total saturated fat intake, highlighting
the difficulty in ascribing a causal outcome to a single
food group. Overall, the data from large observational
studies that demonstrated good follow-up used validated
questionnaires examining multiple dairy foods and con-
ducted appropriate statistical analyses offer important
insight into the association between dairy foods and
CHD [2, 20, 47, 62, 106, 108]. However, the disparate
findings from the present review suggests that the
association between saturated fat intake from dairy foods
and CHD may be weaker than expected by examining
the relationship between national food data sheets and
CHD mortality rates [70, 91]. This is not surprising as
studies investigating national food data are unable to
adequately address the confounding influences of life-
style variables. Of the 12 studies included in the review,
8 were set-up during or before the 1970s when whole
milk was the only type of milk available. Skim and low-
fat milk were introduced in the 1980s. Hence, the results
of early studies may relate to the consumption of high-
fat dairy products as low-fat alternatives only became
available in the latter part of these studies. Disparity
may also be a result of the specific dairy foods exam-
ined by each study and their relationship with CVD.
There is some preliminary evidence that particular dairy
foods may have differential effects of risk factors for
CVD. For example, in a controlled setting, cheese may
have a milder effect on blood cholesterol levels than a
similar quantity of dairy fats from butter. Although
fermented dairy foods have been associated with a mild
reduction in cholesterol in some but not in other studies
[1], no studies included in the review specifically eval-
uated the relationship between fermented dairy foods
and CVD.
Effects of dairy fat on plasma lipid risk factors for CVD
Several decades of scientific investigations have estab-
lished that elevated levels of LDL cholesterol (LDL-C)
are predictive of an increased risk of CVD. This associ-
ation and its apparent responsiveness to diet and lifestyle,
though obtained independently, are the basis for a variety
of population-based interventions spanning from dietary
guidelines to the Cholesterol Education Program in the
US. However, in the last decade, it has become increas-
ingly clear that while high LDL-C levels are an indication
of heart disease risk, the risk of heart disease and overall
morbidity and mortality are also related to low levels of
the other major cholesterol carrier in blood—HDL. The
epidemiologic association between low levels of HDL
and increased risk and, alternatively, high levels of HDL
and protection from a variety of diseases—including heart
disease, infections and inflammation—has been estab-
lished. Intensive research has begun to focus on this
reciprocal relationship between LDL and HDL. Higher
plasma concentrations of LDL-C, its respective apolipo-
protein B (ApoB) and specifically the smaller, dense LDL
particles, higher plasma triacylglycerol concentrations and
low plasma HDL-cholesterol (HDL-C) are associated with
increased risk of heart disease. Alternatively, decreased
risk is associated with higher concentrations of HDL-C
and its apoprotein, apolipoprotein A-I (Apo A-I), and
with greater size and buoyancy of HDL subtypes [103].
Promoting HDL-C is now emerging as an important tar-
get for lowering the risk of CVD in the population. In
order to capture the value of diet as an independent
effector of HDL and its benefits to health by raising
HDL, studies should begin to separate the effects of
dietary intakes on HDL and measure the effects on dif-
ferent lipoprotein metabolites [15]. The benefits of HDL
extend across age groups and health outcomes. For
example, in a population of centenarians, a decrease in
cognitive function was associated with lower HDL-C
[27]. The offspring of individuals with high HDL-C had a
23% lower risk of hypertension, 50% lower risk of dia-
betes mellitus, a 60% lower risk of heart attacks and had
no reported strokes compared with their age-matched
controls [12].
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Milk fat and LDL
Effects of individual fatty acids on LDL
Metabolic studies of the effects of individual fatty acids
have shown that most saturated fatty acids, with the
exception of stearic and short-chain fatty acids, raise LDL-
C significantly [115]. However, the effects of specific fatty
acids vary. In some studies, 16:0 was the major dairy fatty
acid, and it appeared to raise LDL-C to the greatest extent
[75]; in other studies, lauric (12:0) and myristic (14:0)
acids were the fatty acids most effective at raising LDL-C
[66]. Several meta-analyses of published trials highlight
these relationships and provide equations in which their
LDL-C-raising effect is quantified [68]. On the other hand,
cross-sectional studies that have estimated dairy fat con-
sumption from characteristic fatty acids in plasma lipids
have failed to find that the levels of such fatty acids were
necessarily related to higher LDL-C levels [90]. One study
suggested that the nature of the LDL particles might even
be more favorable from a cardiovascular perspective in
subjects with higher levels of typical dairy fatty acids; most
notably, dairy fats raise solely the large and less athero-
genic subpopulation of LDL particles [93]. Such findings
are consistent with the conclusion that simple measures of
total LDL-C are not as predictive of overall cardiovascular
risk as are detailed analyses of LDL subpopulations. The
positional specificity of the fatty acids in the triacylglycerol
molecule may be relevant to the effects of individual fatty
acids on CVD. In milk triacylglycerols, 16:0 occupies the
sn-2 position, which is generally occupied by unsaturated
fatty acids in plants. This unique position of 16:0 ensures
that calcium in milk is highly absorbable by avoiding the
formation of insoluble calcium soaps in the intestine.
Because pancreatic lipase in the gut selectively hydrolyzes
triglycerides at the sn-1 and sn-3 positions, free fatty acids
and 2-monoglycerides are produced. Free palmitic acid, but
not 2-monopalmitin (which is efficiently absorbed), may be
lost as a calcium-fatty acid soap in the feces. The debate
about trans fats has largely bypassed ruminant trans fatty
acids (TFA); but recently, two reports that compared
ruminant TFA with industrial TFA showed that both
sources of TFA (despite different mixtures of TFA) raised
LDL-C similarly [25, 71]. However, as noted, the daily
consumption of ruminant TFA cannot reach the amounts
tested in these studies. For example, the high dose of TFA
from ruminants tested in one of the two studies (3.6% of
daily energy) [71] would correspond to daily consumption
of 10 servings of cheese, 5 servings of whole milk, 2
servings of full-fat yogurt and 20 teaspoons of butter. The
long-term effect of even small amounts of TFA from any
source is the basis of ongoing research. Conjugated linoleic
acid, a small component of dairy fats, is a trans fatty acid
that is unlike other trans fatty acids in its biological effects.
The effects on plasma lipids of conjugated linoleic acid
have been generally disappointing in human clinical trials
compared with animal studies. When enriched in dairy fats,
the major isomer, cis-9, trans-11 conjugated linoleic acid,
has failed to lower LDL-C when consumed in amounts
exceeding that currently present in dairy foods [104].
Effects of fermented versus non-fermented dairy foods
on LDL
Interest in the possibility that fermented foods, including
dairy foods, may confer health benefits has been long
standing and may be on the increase. It is likely that milk
fat alone may not be sufficient to induce adverse effects on
plasma lipids, such effects being modified by other factors
in specific dairy foods. The epidemiology relating to total
dairy consumption or that measured as milk consumption
has been interpreted differently in different publications.
Although at least one large meta-analysis of prospective
studies failed to find a significant association between
cardiovascular events and milk consumption [34], in eco-
logical, observational studies a positive relationship
between dairy intake and heart disease has been reported
[7, 34]. Of interest, however, is that two large analyses of
the association between dairy fat consumption and CHD
mortality—both finding the association to be positive—
noted that cheese intake was exceptional in being not
unfavorable [7, 87]. A specific analysis of the effects of
eating cheese on CHD has not been reported, although in
one analysis, there was a negative trend between CHD and
cheese consumption whereas the association with milk was
positive [70]. Three recently published trials comparing the
influence on plasma lipids of different dairy foods at sim-
ilar intakes of dairy fat suggest that eating hard cheese has
a lesser LDL-C-raising effect than that of butter or milk
[17, 76, 101]. Although differing in design and indeed in
the type of cheese tested, the concordance of the conclu-
sions is striking. The mechanism is uncertain; fermentation
of milk and the potential hydrolysis of lipids and proteins
may be one factor, the lipids are physically in different
states and potential protective compounds or structures
such as calcium or phospholipids may be removed during
the production of butter. There are studies in which fer-
mented dairy foods appeared to lower plasma cholesterol
when compared with the non-fermented products. This has
been more suggestive with yoghurts, although the nature of
the microflora and their capacity to survive and colonize
the gut have been major variables. Other studies have
failed to show lowering of LDL-C by fermented dairy
foods. The overall conclusions in reviews of the subject
concede that the case for plasma cholesterol reduction with
fermented dairy foods still requires proof [98, 100].
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Milk fat and HDL
One of the established properties of milk fat relative to
polyunsaturated oils is the increase in concentration of HDL
in plasma [44, 67, 93]. It is recognized from clinical,
mechanistic and epidemiologic studies that HDL-C levels
are an independent predictor of heart disease. Substantial
epidemiological research has shown negative associations
of HDL-C and heart disease—high HDL-C is associated
with protection from heart disease, even in the face of ele-
vated LDL-C, and low HDL-C is associated with increased
risk, with or without elevated triglycerides. However, it has
not been possible to assign independent variables to HDL-C
differences, and studies have largely been based on HDL-C
levels that are presumably high or low based on genetic
rather than dietary determinants [78, 111, 113]. HDL are
thought to exert beneficial effects on overall health by
separate mechanisms, including reverse cholesterol trans-
port and also, binding and eliminating toxins, delivering
bioactive compounds, protecting various cells and lipopro-
teins from damage and participating in their repair [6, 11,
24, 84, 112]. The bacterial toxin lipopolysaccharide is
associated with plasma lipoproteins, suggesting that its
sequestration by lipid particles may form an integral part of
a humoral detoxification mechanism [35, 59, 60, 81, 109].
HDL inhibit the oxidation of LDL via the paraoxonase
enzyme activity bound to HDL, and HDL are also capable
of removing oxidized lipids directly from LDL [73]. The
ability of HDL to protect LDL from oxidation would be
expected to improve the early stages of development of
LDL-laden macrophages within the artery wall and also to
inhibit later stage inflammation and plaque rupture [99].
Replacement of saturated fat by carbohydrates: effects
on plasma lipid risk factors for CVD
Early dietary interventions sought to demonstrate a bene-
ficial effect of reducing saturated fat on CVD events or
mortality, and while some [28, 58, 105], though not all [38,
69], of these studies resulted in reduced CVD risk, it is
important to note that these diets replaced saturated fat
with polyunsaturated fat. Clinical trials in which replace-
ment of saturated fat occurs in the context of reduced total
fat and increased carbohydrate have generally not been
associated with improvements in CVD [14, 23]. Recently,
the Women’s Health Initiative showed no benefit on CVD
of reducing total fat from 37% to 29% in a cohort of 48,000
post-menopausal women [45]. In the Women’s Health
Initiative, saturated fat was reduced from 12.4 to 9.5%,
polyunsaturated fat was reduced by 1.5% and dietary car-
bohydrate was increased by *8%. A number of large
prospective epidemiological studies have not shown a
relationship of saturated fat with CVD [8, 46, 47]. In the
Nurses’ Health Study, polyunsaturated fats and trans fats
from industrial sources were identified as being inversely
and positively, respectively, associated with increased
CHD risk [46, 80]. Notably, the polyunsaturated fat:satu-
rated fat (P:S) ratio appeared to be strongly and inversely
associated with CHD risk, such that P:S ratios C0.49 were
associated with decreased CHD events[8]. This finding is
in line with the data from the clinical trials cited above in
which the benefit of reducing saturated fat occurred in the
context of diets that were high in polyunsaturated fat [28,
58, 105]. There are also several studies, which have cited
inverse associations of dietary saturated fat with CVD. In
particular, a handful of studies [40, 51, 52], though not all
[43], have suggested that saturated fat intake is associated
with decreased risk of ischemic or hemorrhagic stroke. In a
study in post-menopausal women, saturated fat was asso-
ciated with decreased progression of coronary
atherosclerosis and dietary carbohydrate was associated
with increased progression of the disease [72]. Overall, the
data from clinical trials and epidemiology do not support
an independent role for saturated fat in the determination of
CVD risk. The P:S ratio in the diet appears to be the factor
most strongly associated with reduced risk. The main effect
of saturated fat intake on CVD risk is thought to be med-
iated by elevation of LDL-C [66]. Numerous animal and
cellular studies have shown that saturated fat raises LDL-C,
in part via suppressing LDL receptor activity. Replacement
of saturated fat with polyunsaturated fat has been shown to
reduce LDL-C [44]. Further, the ability of saturated fat to
raise LDL-C may depend on a polyunsaturated fat content
below a threshold level (*5% of energy) [114]. Dietary
carbohydrate can also modulate the effect of saturated fat
on lipid and lipoprotein profiles. Dietary carbohydrate
increases plasma triglyceride concentrations, reduces
HDL-C and increases concentrations of small, dense
LDL—the subclass of LDL that is considered to be more
atherogenic—by increasing hepatic triglycerides, which
drives the secretion of large, triglyceride-enriched particles
[57]. Replacement of saturated fat with carbohydrate
results in reductions in both total cholesterol and HDL-C,
with no effects on the ratio of total cholesterol to HDL-C
[67]. Recently, it was demonstrated that in the context of
lower carbohydrate diets (26% of total energy), lower
versus higher levels of dietary saturated fat had no effect on
small, dense LDL concentrations [56]. However, the higher
concentrations of saturated fat were associated with
increases in larger LDL particles, thereby resulting in no
change in plasma levels of LDL-C, in contrast to the
reductions observed with the lower carbohydrate, low-sat-
urated fat diet. Saturated fat may also influence CVD risk
through lipid-independent mechanisms, including effects
on lowering insulin sensitivity [26, 89, 107], increasing
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thrombosis [13], increasing inflammatory markers [13, 16],
compromising vascular function [77] and raising blood
pressure [86]. However, the evidence relating saturated fat
and the aforementioned risk factors remains inconclusive
and will require further investigation. In the next section,
the effects of dairy foods on non-lipid CVD risk are
discussed.
Effects of dairy foods on non-lipid risk factors for CVD
Studies describing the association between dairy product
intake and the risk of CVD have been inconsistent. In large
epidemiological studies, consumption of high-fat dairy
products has been associated with an increase in CVD risk,
while intake of low-fat dairy foods has not [47]. On the
other hand, a recent survey of publications available on this
topic suggested that a high consumption of any type of
milk versus a low consumption found no association with
an increased risk of CVD [34]. This apparent lack of
association between dairy consumption and CVD risk in
many studies may appear as being counterintuitive because
dairy products contribute significantly to intake of satu-
rated fatty acids, a key LDL-C-raising factor. Yet,
investigators are just beginning to unravel and appreciate
the complexity of the dairy food matrix and its effects on
several other CVD risk factors. At the same time, there is a
growing recognition of the contribution of risk factors
unrelated to LDL but nonetheless contributing to the
pathophysiology of CVD. The following section provides
an overview of the effects of dairy foods per se and of their
individual components on non-lipid CVD risk factors such
as blood pressure, inflammation, insulin resistance and type
2 diabetes, obesity and the metabolic syndrome.
Dairy and blood pressure
The association between intake of dairy products, calcium,
and vitamin D and the risk of developing hypertension has
been extensively investigated. In a prospective cohort of
28,886 US women aged C45 years followed over a period
of 10 years, a high intake of low-fat dairy products (highest
vs. lowest quintile) was associated with a significant 11%
reduction in the risk of developing hypertension [111].
Interestingly, this reduction in risk was also significant
across quintiles of dietary calcium and dietary vitamin D,
but was not significant across quintiles of calcium or vitamin
D supplements. The positive association between intake of
low-fat dairy products and reduced hypertension was sig-
nificantly attenuated after adjustment for dietary calcium
but not after adjustment for vitamin D. Finally, intake of
high fat dairy products showed no association with the risk
of hypertension in multivariate analysis. This large study in
middle-aged and older women emphasized the notion that
high fat and low-fat dairy products may not similarly affect
blood pressure and, hence, the risk of CVD. Perhaps one of
the most acknowledged studies on the association between
dairy foods and blood pressure is the multicenter Dietary
Approach to Stop Hypertension (DASH) study [5]. In the
DASH study, the diet rich in fruits and vegetables and low-
fat dairy products reduced systolic blood pressure by
5 mmHg more and diastolic pressure by 3.0 mmHg more
than the control diet. About 50% of the magnitude in these
reductions could be ascribed to the dairy foods per se in the
diet. It has been estimated that a population-wide reduction
in systolic or diastolic blood pressure with the magnitude
observed with the DASH diet would reduce incidence of
CHD by approximately 15% and stroke by approximately
27% [5]. Calcium is thought to be one of the main nutrients
responsible for the impact of dairy products on blood
pressure [63]. Other minerals such as magnesium and
potassium may also regulate blood pressure, but their indi-
vidual contributions have been difficult to isolate and
quantify because they most frequently occur in foods that
are also rich in calcium [88]. Both casein and whey proteins
are a rich source of specific bioactive peptides that have
been shown to have an angiotensin-I-converting enzyme
inhibitory effect, a key process in blood pressure control
[36]. Studies have also suggested that certain peptides
derived from milk proteins may modulate endothelin-1
release by endothelial cells, thereby partly explaining the
anti-hypertensive effect of milk proteins [61].
Dairy and inflammation
Inflammation and oxidative stress are being increasingly
recognized as key etiological factors in the development of
atherosclerosis and subsequent CVD. A recent study
showed that tumor necrosis factor-a, interleukin-6 and
monocyte chemoattractant protein-1 gene expression were
markedly decreased in the adipose tissue of ap2-agouti
mice fed a high calcium or a high dairy diet, with a cor-
responding diet-induced increase in adiponectin expression
compared with the basal diet [117]. Consistent with these
findings, 24 weeks of feeding a high-dairy eucaloric diet
and hypocaloric diet in overweight men and women led to
a clinically meaningful reduction in plasma C-reactive
protein (11 and 29%, respectively) and to a reciprocal
increase in plasma adiponectin concentrations (8 and 18%,
respectively) [117]. These data suggested that dietary
components including calcium and or its unique proteins,
the peptides they release, the phospholipids associated with
milk fat or the stimulation of HDL by lipids themselves,
may suppress adipose tissue oxidative and inflammatory
stress. They also emphasized that dairy foods may benefi-
cially alter circulating C-reactive protein and adiponectin
196 Eur J Nutr (2009) 48:191–203
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levels independently of changes in body weight. The extent
to which these mechanisms per se may contribute to
apparent cardioprotective properties of dairy foods on the
development of CVD remains to be more thoroughly
demonstrated.
Dairy and type 2 diabetes
Observational studies show a relatively consistent associ-
ation between low vitamin D status, or low calcium or
dairy intake and prevalent type 2 diabetes. A recent review
of published studies indicated that the prevalence of type 2
diabetes was 64% lower among non-blacks for highest
versus lowest 25-hydroxyvitamin D intake [83]. Inverse
associations of vitamin D and calcium intake with type 2
diabetes have also been observed. Specifically, highest
versus lowest combined vitamin D and calcium intake has
been associated with an 18% reduction in type 2 diabetes,
while highest versus lowest dairy intake may reduce the
risk of type 2 diabetes by 14% [83]. The available literature
suggests that the reduction in the risk of type 2 diabetes
associated with combined vitamin D and calcium supple-
mentation may be significant only in populations at high
risk such as those with glucose intolerance. However, it is
stressed that the available evidence relating dairy foods,
calcium and vitamin D to type 2 diabetes is limited because
most observational studies were cross-sectional and did not
adjust for important confounders, while intervention stud-
ies were generally short in duration and had limited
statistical power due to small sample size [26, 89, 107].
Thus, it is generally agreed that more data are required,
particularly from controlled clinical studies, to quantify the
efficacy of dairy products in modulating the risk of type 2
diabetes.
Dairy and obesity/metabolic syndrome
The replacement of starchy carbohydrates with protein from
lean meat and low-fat dairy ingredients has been suggested
to enhance satiety, thereby facilitating weight control [10].
Dairy calcium per se is thought to promote weight loss
[116], although the mechanism of action remains unclear.
The metabolic syndrome has recently emerged as a clinical
concept with important implications in terms of CVD risk
management. The prevalence of the metabolic syndrome
has been estimated to be around 25% in industrialized
countries, and figures increase with age [37]. Epidemio-
logical studies have shown that patients with the metabolic
syndrome have a 2–5-fold greater risk of CVD than meta-
bolic syndrome-free individuals [30]. In many studies, dairy
consumption has been inversely associated with the
occurrence of one or several facets of the metabolic syn-
drome. In the CARDIA study that involved 3,157 adults
aged 18–30 years, consumption of C5 servings/day of dairy
products versus \1.5 servings/day was associated with a
70% reduction in the risk of having the metabolic syndrome
over a period 10 years [82]. However, this has not been a
consistent finding. In an elderly Dutch population, higher
dairy consumption has not been associated with lower
weight or with a more favorable profile of risk factors
associated with the metabolic syndrome, except for a
modest association with lower blood pressure [94].
Dairy products as essential contributors
of micronutrients in reference food patterns: lessons
from elderly people for the entire population
The intake of common liquid milk has declined or stag-
nated over the last decade, especially in Europe and North
America [49, 50]. Consumers, but also nutritionists, tend to
forget that milk contains a wide variety of important
nutrients such as protein, calcium, zinc and vitamins B2,
B12 and D. This implies that reducing dairy consumption
as a means to lower saturated fat intake could create a
number of nutritional issues in populations. The most
systematic examination of this issue has been pursued in
the elderly, though the results are important for all ages. In
the current daily food pattern of older adults in The
Netherlands and other European countries, it seems hard to
replace dairy by other products without risk for inadequate
intakes of some of these nutrients.
Micronutrient contribution of dairy products to daily
food patterns
From the third Dutch National Food Consumption Survey
(1998) [110], the contribution of milk (products) and
cheese to daily intake of selected nutrients of Dutch age
groups was calculated, allowing comparisons between age
groups. Table 1 shows the comparison between the total
population and the age category above 65 years. Evident in
these data are the large contributions of dairy products to
intake of calcium (69–75%), vitamins B2 (46–50%) and
B12 (30–37%), protein (*25%) and zinc (*25%). Lower,
but still significant contributions can be noted for dietary
intake of magnesium (17–18%), vitamins B6 (10–14%), B1
(10–11%) and B11 (folic acid) (6–9%), retinol (7–8%),
vitamin D (7–9%) and selenium (14–17%). Contributions
to the intake of energy, fat and saturated fat were 15–16%,
*18% and 27–29%, respectively. A more recent intake
assessment on these nutrients for younger adults (19–
30 years) was reported in 2003 [48]. From Table 1 it can
be concluded that nutrient contributions through dairy
intake in The Netherlands are rather similar for younger
adults and adults aged above 65 years. Such a similarity is
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also present in current recommendations on food based
dietary guidelines where daily intakes of 450–650 mL and
30–20 g for milk (products) and cheese, respectively, are
recommended for each of the three age categories of 19–
50, 50–70 and over 70 years. These food-based dietary
guidelines aim to promote balanced food and nutrient
intake, whereby saturated fat content is one of the criteria
used to classify foods as ‘‘preferred foods.’’ The SENECA
survey on nutrition and the elderly has shown that dairy
intakes may differ considerably between different regions
in Europe [97]. Potential concerns were identified with
respect to dietary intake of vitamins D and B12, but also in
relation to, respectively, insufficient sun exposure/skin
synthesis and reduced absorption efficiency [42]. Together
with calcium, these nutrients appear to have the highest
priority in terms of multiple health outcomes for the elderly
population, and more in particular to prevention of osteo-
porotic fractures [18, 19, 27, 31, 96]. The B-vitamins (B6,
B11 and B12) have also been associated with cognitive
functioning in the elderly, yet available evidence so far
does not allow for firm conclusions due to heterogeneity in
study designs and methods applied [85]. Milk products are
good carriers for enrichment with vitamins D, B11 and B12
[32, 53, 79].
For the diet of the fragile elderly, other deficiencies—
such as for protein, vitamins B1, B2 and B11—are mainly
due to inadequate food intake. As loss of body weight or
skeletal muscle mass is common in older persons, inade-
quate intake of protein and energy may result in clinically
relevant reductions in strength, exercise capacity and
mobility [102].
Dietary patterns versus food items as predictors
of survival in the elderly population
Diet and lifestyle influence morbidity and mortality during
the course of life [9]. Ten-year mortality from all causes, or
specifically from CVD or cancer, has been investigated in
1,507 apparently healthy men and 832 women, aged 70–
90 years in 11 European countries. In this so-called HALE-
project (Healthy ageing: a longitudinal study in Europe),
adherence to a defined Mediterranean diet and healthful
lifestyle (moderate alcohol use, physical activity and non-
smoking) was associated with a [50% lower rate of all-
causes and cause-specific mortality [54]. Attempts have
been made to assess the predictive value for survival of
Mediterranean diet scores in relation to intake of milk
(products) in northern versus southern European countries.
Table 1 Contribution (%) of dairy products to the daily intake of energy, macro- and micronutrients; data derived from Dutch National Food
Consumption Surveys (DNFCS) in 1998 and 2003
Energy and nutrients DNFCS 1998
Total population (n = 5,958)
DNFCS 1998
Older adults (65?)
DNFCS 2003
Young adults (19–30)
Men
(n = 185)
Women
(n = 236)
Men
(n = 352)
Women
(n = 398)
Milk
(products)
Cheese Milk
(products)
Cheese Milk products Cheese All dairy products
Energy 11.1 4.5 10.3 4.7 11.9 4.6 13.9 15.3
Protein 17.8 8.3 16.7 8.8 19.4 8.4 24.1 26.5
Fat 9.1 8.9 9.7 8.8 9.2 8.6 17.6 18.8
Saturated fat 14.9 14.0 13.5 13.5 14.0 13.1 30.4 31.4
Calcium 47.7 21.1 45.8 23.6 54.8 20.2 65.6 62.6
Magnesium 15.0 2.6 14.2 2.7 15.7 2.6 15.1 17.0
Zinc 15.6 9.7 14.8 10.0 16.3 9.2 24.8 26.7
Selenium 10.5 6.9 9.3 5.4 11.0 5.5 12.5 13.9
Retinol 8.0 8.2 6.8 6.7 7.8 7.4 14.6 15.5
Vitamin D 5.1 4.1 3.9 3.2 4.4 3.5 9.2 10.2
Vitamin B1 10.0 0.7 9.0 0.7 10.4 0.7 12.7 13.0
Vitamin B2 45.5 3.7 42.8 3.7 47.1 3.4 45.1 47.7
Vitamin B6 9.0 1.1 13.0 1.1 9.8 1.0 10.1 12.0
Vitamin B11 7.9 1.1 6.5 0.1 8.0 0.1 11.1 13.5
Vitamin B12 34.7 2.4 28.0 2.0 33.9 2.2 33.5 36.7
The 1998 DNFCS data were based on records for two sequential days of food items noted in a diary; the 2003 data were based on computer-
assisted 24-h diet recall interviews by trained dieticians on two independent days. The 1998 data for vitamins B11 and B12 were calculated by the
authors
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Hazard ratios were different for men and women, and were
also dependent on the cut-off values chosen for intake.
More beneficial hazard ratios were found when the optimal
intake of milk and milk products (excluding butter) was
defined as the intake between the P25 and P75 percentile,
rather than above or below the median intake (P50). The
inconsistencies could not be explained by variations in
intake per study site. The P25–P75 cut-off values for men
and women were, respectively, 144–474 g/day and 159–
465 g/day [103]. The HALE population was also investi-
gated for the association of total cholesterol, HDL, LDL-C
and VLDL-C and 10-year mortality from CVD and all
causes. During follow-up, 302 deaths were due to CVD.
From the assessed lipid fractions, only a significant inverse
association was found between HDL-C and cardiovascular
and all-cause mortality; the highest tertile had a significant
lower risk of mortality from CVD (HR: 0.72, 95% CI:
0.54–475 0.95) and all causes (HR: 0.80, 95% CI: 0.66–
0.96) compared with the lowest tertile. These associations
remained significant after adjustments for gender, age,
education, BMI, smoking, study centre and LDL-C and
VLDL-C [55].
Conclusion
The dairy sector has made continuous advancement over
the years, and today there is a wide variety of milks and
dairy products readily available to the consumer. The
important contributions of these products in meeting human
dietary requirements for energy, high quality protein, and
several key minerals and vitamins are well documented,
though the nutritional importance of dairy fats is often less
well understood. In particular, there has been a general
perception that a food containing saturated fat is unlikely to
be beneficial to health. The purpose of this review and the
conference that preceded its compilation was, therefore, to
provide an overview and reappraisal of the available sci-
entific evidence examining the impact of dairy foods on
CVD risk. Dairy products contribute to the saturated fatty
acid composition of the diet. Nonetheless, a systematic
review of prospective cohort studies, and the disparities
among them, indicated that there is no clear evidence that
dairy food consumption is consistently associated with a
higher risk of CVD. Of the major types of dairy food,
limited evidence to date indicates that cheese appears most
likely to be associated with reduced CVD risk. This may
reflect the diminished LDL-raising effect of eating cheese
compared with the consumption of similar amounts of fat
from butter or milk. Much investigation of the effects of
other fermented dairy foods has failed to show unequivo-
cally a cholesterol-lowering effect. Furthermore, whereas
saturated fats in general are often considered to raise LDL-
C, it is important to note that not all saturated fatty acids in
milk fat do so, with 18:0 and very short-chain fatty acids
being neutral in terms of effects on LDL-C. Although it
remains clear that high LDL-C levels are an indication of
CVD risk, low levels of HDL-C are also strongly related to
CVD risk, and milk fat has been shown to increase plasma
HDL-C levels. This, along with emerging evidence of the
importance of small dense LDL as a CVD risk factor, and
the evidence that levels of these particles are not influenced
by saturated fat, warrants further investigation in assigning
the overall health implications of dairy food consumption.
Whereas the impact of dairy foods on blood pressure is
almost beyond debate, their effects on body weight and
other non-lipid risk factors need to be further substantiated.
Nevertheless, the purported inverse association between
dairy foods, particularly low-fat dairy products, and inci-
dence of the metabolic syndrome is suggestive of
cardiovascular benefits that may go well beyond the effect
of dairy fat on blood lipids. The potential impact of dairy
foods on inflammation and oxidative stress is also consis-
tent with this hypothesis. These associations may explain
why intake of dairy products in most epidemiological
studies has not been associated with an increased cardio-
vascular risk. Although further research is required to better
understand the impact of dairy foods on non-lipid risk
factors, there is accumulating evidence that a high intake of
dairy products, particularly low-fat products, may in fact be
beneficial from a heart health perspective. Further recom-
mendations to reduce saturated fat in the diet below current
guidelines should be made with caution and in context,
because replacement with dietary carbohydrate can result in
the increasingly common triad of lipid abnormalities—
elevations in triglyceride, and reductions in HDL-C and
small, dense LDL—which has been shown to confer
increased CVD risk. Furthermore, continued recommen-
dations to reduce milk fat intake may result in inadequate
intakes of key nutrients in certain population groups. In
summary, despite the contribution of dairy products to the
saturated fatty acid intake of the diet, there is no clear
evidence that dairy food consumption is consistently
associated with a higher risk of CVD. Given the diversity of
available dairy foods of widely differing composition and
their contribution to nutrient intake within the population,
recommendations to reduce dairy food consumption irre-
spective of the nature of the dairy product should be made
with caution.
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